Latest News about VNDA
Recent news which mentions VNDA
Stocks That Hit 52-Week Lows On Wednesday
August 30, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
July 31, 2023
From Benzinga
From Benzinga
A Sea Change in Motion Sickness Therapy: Vanda Pharmaceuticals' Tradipitant Shows Promising Data in Real-world Test
May 25, 2023
Tickers
VNDA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 04, 2023
From Benzinga
Court Favors Vanda In Case Against FDA Over Detail Disclosure Of Rejection Of Sleep Disorder Drug
March 29, 2023
Tickers
VNDA
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
From Benzinga
Why Vanda Pharmaceuticals Stock Crawled Higher Today
February 09, 2023
Tickers
VNDA
From Motley Fool
Vanda Pharma's Antipsychotic Shows Improved Severity In Bipolar Disorder
December 19, 2022
Tickers
VNDA
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
From Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 13, 2022
From Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
From Benzinga
Earnings Scheduled For November 2, 2022
November 02, 2022
From Benzinga
Looking Into Vanda Pharmaceuticals's Return On Capital Employed
August 10, 2022
Tickers
VNDA
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 5, 2022
May 05, 2022
From Benzinga
This Hidden Stock Exploded by 190% in a Day. Is It a Buy?
April 16, 2022
From Motley Fool
93 Biggest Movers From Friday
February 28, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
February 25, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.